Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.

Autor: Karci E; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul 34214, Türkiye., Bilici A; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul 34214, Türkiye., Bayram B; Department of Medical Oncology, Koc University Hospital, Istanbul 34010, Türkiye., Celayir M; Department of Medical Oncology, Faculty of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul 34752, Türkiye., Ozyurt N; Department of Medical Oncology, Faculty of Medicine, Ordu University Training and Research Hospital, Ordu 52200, Türkiye., Uluc BO; Department of Medical Oncology, Faculty of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul 34752, Türkiye., Eken A; Department of Medical Oncology, Ozel Ortadogu Hospital, Adana 67055, Türkiye., Basaran G; Department of Medical Oncology, Faculty of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul 34752, Türkiye., Demirci U; Medical Oncology Unit, Memorial Ankara Hospital, Ankara 06520, Türkiye., Kemal Y; Department of Medical Oncology, Faculty of Medicine, Altınbas University, Istanbul 34147, Türkiye., Oruncu MB; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara 06100, Türkiye., Olmez OF; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul 34214, Türkiye., Selcukbiricik F; Department of Medical Oncology, Koc University Hospital, Istanbul 34010, Türkiye., Korkmaz T; Department of Medical Oncology, Faculty of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul 34752, Türkiye., Erturk I; Ministry of Health Gülhane Training and Research Hospital, Ankara 06010, Türkiye., Bilgetekin I; Medical Oncology Unit, Memorial Ankara Hospital, Ankara 06520, Türkiye., Celik S; Department of Medical Oncology, Yeditepe University, Istanbul 34755, Türkiye., Turkel A; Department of Medical Oncology, Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara 06200, Türkiye., Alkan A; Department of Medical Oncology, School of Medicine, Mugla Sıtkı Kocman University, Mugla 48000, Türkiye., Sakin A; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul 34214, Türkiye., Can O; Department of Medical Oncology, Faculty of Medicine, Mehmet Ali Aydınlar Acıbadem University, Istanbul 34752, Türkiye., Gunaldi M; Department of Medical Oncology, Faculty of Medicine, Aydın University, Istanbul 34295, Türkiye., Esin E; Department of Medical Oncology, Bayındır Hospital, Ankara 06250, Türkiye., Yildiz O; Department of Medical Oncology, Faculty of Medicine, İstanbul Medipol University, Istanbul 34214, Türkiye.

Publikováno v: Cancers [Cancers (Basel)] 2024 Oct 03; Vol. 16 (19). Date of Electronic Publication: 2024 Oct 03.

Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.

Autor: Karacin C; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, Turkey., Sunar V; Depatment of Medical Oncology, Losante Children & Adult Hospital, Ankara, Turkey., Urakci Z; Departmen of Medical Oncology, Dicle University, Diyarbakir, Turkey., Yilmaz A; Department of Medical Oncology, Atatürk University Training Hospital, Erzurum, Turkey., Ayhan M; Department of Medical Oncology, Kartal Training & Research Hospital, Istanbul, Turkey., Ersoy M; Department of Medical Oncology, Osmangazi University, Eskisehir, Turkey., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Erturk I; Department of Medical Oncology, University of Health Sciences, Gulhane Training & Research Hospital, Ankara, Turkey., Durmus Y; Department of Gynecology, Etlik Zubeyde Hanim Training & Research Hospital, Ankara, Turkey., Karacin P; Department of Gynecology, Etlik Zubeyde Hanim Training & Research Hospital, Ankara, Turkey., Boran N; Department of Gynecology, Etlik Zubeyde Hanim Training & Research Hospital, Ankara, Turkey., Ustun YE; Department of Gynecology, Etlik Zubeyde Hanim Training & Research Hospital, Ankara, Turkey., Meydan M; Department of Gynecology, Zekai Tahir Burak Training & Research Hospital, Ankara, Turkey., Dogan M; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, Turkey., Oksuzoğlu B; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, Turkey., Ates O; Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, Turkey., Karaca M; Department of Medical Oncology, Antalya Training & Research Hospital, Antalya, Turkey., Uncu D; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey., Ergun Y; Department of Medical Oncology, Antalya City Hospital, Antalya, Turkey., Arik Z; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Future oncology (London, England) [Future Oncol] 2024 Feb; Vol. 20 (4), pp. 207-214. Date of Electronic Publication: 2024 Feb 08.

702P Survival and related factors in testicular non-seminomatous patients undergoing high-dose chemotherapy and autologous stem cell transplantation: Experience of Turkey's highest volume transplantation center

Autor: Aykan, M.B., Erturk, I., Acar, R., Keskin, G.S.Y., Kose, A.F., Karadurmus, N.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S541-S541

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.

Autor: Akyildiz A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Ozluk AA; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Ismayilov R; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey., Mutlu E; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey., Unal OU; Department of Medical Oncology, Bozyaka Education and Research Hospital, Izmir, Turkey., Yildiz I; Department of Medical Oncology, Acibadem University Hospital, Istanbul, Turkey., Iriagac Y; Department of Medical Oncology, Namik Kemal University, Tekirdag, Turkey., Turhal S; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Akbas S; Department of Medical Oncology, Koc University Hospital, Istanbul, Turkey., Bayram E; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Telli TA; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey., Turkoz FP; Department of Medical Oncology, Istinye University, Medical Park Goztepe Hospital, Istanbul, Turkey., Ozcelik M; Department of Oncology, Kartal Lutfi Kirdar Teaching and Research Hospital, Istanbul, Turkey., Erciyestepe M; Department of Medical Oncology, Prof Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Selvi O; Department of Medical Oncology, Prof Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Gulbagci B; Department of Medical Oncology, Sakarya University Faculty of Medicine, Sakarya, Turkey., Erturk I; Department of Medical Oncology, Gulhane School of Medicine, Ankara, Turkey., Isleyen ZS; Department of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey., Kahraman S; Department of Medical Oncology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey., Akdag MO; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Hamitoglu B; Department of Medical Oncology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey., Unek IT; Department of Medical Oncology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., Hacibekiroglu İ; Department of Medical Oncology, Prof Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Arslan C; Department of Medical Oncology, Izmir University of Economics Faculty of Medicine, Izmir, Turkey., Azizy A; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey., Helvaci K; Department of Medical Oncology, Memorial Ankara Hospital, University of Uskudar, Ankara, Turkey., Demirci U; Department of Medical Oncology, Memorial Ankara Hospital, University of Uskudar, Ankara, Turkey., Dizdar O; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Basaran M; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey., Goker E; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Sendur MA; Department of Medical Oncology, Ankara City Hospital, Yildirim Beyazit University, Ankara, Turkey., Yalcin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Medicine [Medicine (Baltimore)] 2023 Nov 10; Vol. 102 (45), pp. e35950.

Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.

Autor: Acar R; Department of Medical Oncology, Mersin City, Research and Training Hospital, University of Health Science, Mersin, Turkey., Paydaş S; Department of Medical Oncology, School of Medicine, University of Cukurova, Adana, Turkey., Yıldırım M; Department of Hematology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey., Kılıçarslan E; Department of Medical Hematology, Sultan Abdulhamid Han Research and Training Hospital, University of Health Science, Istanbul, Turkey., Sahın U; Department of Hematology, Medicana International Hospital, Ankara, Turkey., Dogan A; Department of Hematology, Van Yuzuncu Yil School of Medicine, University of Van Yuzuncu Yil, Van, Turkey., Guven DC; Department of Medical Oncology, Hacettepe School of Medicine, University of Hacettepe, Ankara, Turkey., Ekıncı O; Department of Hematology, Fırat School of Medicine, University of Fırat, Elazıg, Turkey., Tıglıoglu M; Department of Hematology, Dıskapı Research and Training Hospital, University of Health Science, Ankara, Turkey., Erdogan I; Department of Hematology, Goztepe Research and Training Hospital, University of Istanbul Medeniyet, Ankara, Turkey., Elıbol T; Department of Hematology, Goztepe Research and Training Hospital, University of Istanbul Medeniyet, Ankara, Turkey., Kızıloz H; Department of Urology, Nevsehir Government Hospital, Nevsehir, Turkey., Aykan MB; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey., Sayın S; Department of Medical Oncology, School of Medicine, University of Cukurova, Adana, Turkey., Kaptan K; Department of Medical Hematology, Sultan Abdulhamid Han Research and Training Hospital, University of Health Science, Istanbul, Turkey., Soydan E; Department of Hematology, Medicana International Hospital, Ankara, Turkey., Gokmen A; Department of Hematology, Medicana International Hospital, Ankara, Turkey., Esen R; Department of Hematology, Van Yuzuncu Yil School of Medicine, University of Van Yuzuncu Yil, Van, Turkey., Barısta I; Department of Medical Oncology, Hacettepe School of Medicine, University of Hacettepe, Ankara, Turkey., Albayrak M; Department of Hematology, Dıskapı Research and Training Hospital, University of Health Science, Ankara, Turkey., Erturk I; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey., Yıldız B; Department of Medical Oncology, Medical Park Hospital, Ankara, Turkey., Keskın GY; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey., Aylı M; Department of Hematology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey., Karadurmus N; Department of Medical Oncology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S138-S144.